Brief: Aquestive Therapeutics Announces That FDA Will Not Require An Advisory Committee Meeting To Discuss New Drug Application For Anaphylm™
04/09/2025 12:01
Aquestive Therapeutics Inc AQST.O: AQUESTIVE THERAPEUTICS ANNOUNCES THAT FDA WILL NOT REQUIRE AN ADVISORY COMMITTEE MEETING TO DISCUSS NEW DRUG APPLICATION FOR ANAPHYLM™ AQUESTIVE THERAPEUTICS INC - PDUFA TARGET ACTION DATE FOR ANAPHYLM IS JANUARY 31, 2026 Source text: ID:nGNX8SqwGh Further company coverage: AQST.O
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Aquestive rises on US licensing deal for seizure drug with Eton Pharma